ACON vs BGLC: stock comparison and AI forecast
Aclarion, Inc. (ACON) and Bionexus Gene Lab Corp (BGLC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ACON Aclarion, Inc.
- Market Cap
- $5M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
BGLC Bionexus Gene Lab Corp
- Market Cap
- $3M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ACON is 1.8 times larger than BGLC by market capitalization ($5M against $3M).
- BGLC carries 0.12 times debt per unit of equity, against 0.06 times for ACON.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ACON | BGLC |
|---|---|---|
| Market Cap | $5M | $3M |
| P/B Ratio | 0.31x | 0.38x |
| EPS | $-13.32 | $-0.16 |
| Book Value/Share | $5.90 | $2.65 |
| Revenue/Share | $0.04 | – |
Profitability & Margins
| Metric | ACON | BGLC |
|---|---|---|
| ROIC | -65.9% | -27.0% |
| Gross Margin | 13.4% | 15.5% |
| Operating Margin | -10901.8% | -43.6% |
| EBT Margin | -10932.4% | -44.0% |
| Tax Rate | 0.0% | 0.0% |
Financial Health
| Metric | ACON | BGLC |
|---|---|---|
| Current Ratio | 16.20x | 6.08x |
| Quick Ratio | – | 5.28x |
| D/E Ratio | 0.06x | 0.12x |
| Financial Leverage | 1.06x | 1.12x |
| Interest Coverage | -3.8x | -474.6x |
| Working Capital | $16M | $4M |
Cash Flow
| Metric | ACON | BGLC |
|---|---|---|
| Operating Cash Flow | -$8M | -$3M |
Operational Efficiency
| Metric | ACON | BGLC |
|---|---|---|
| Asset Turnover | 0.01x | – |
| Receivables Turnover | 3.6x | – |
| Inventory Turnover | – | 6.3x |
| Fixed Assets Turnover | 4.4x | – |
| Days Sales Outstanding | 100 days | – |
| Days Inventory | – | 58 days |
| Payables Period | 2890 days | 54 days |
Income Statement
| Metric | ACON | BGLC |
|---|---|---|
| Total Revenue | $100K | – |
| Operating Income | -$11M | -$2M |
| R&D Expense | $1M | $60K |
| SG&A Expense | $10M | – |
| Cost of Goods Sold | $90K | $4M |
Dividend & Shareholder Information
| Metric | ACON | BGLC |
|---|---|---|
| Shares Outstanding | 3M | 3M |
ACON vs BGLC: stock comparison and AI forecast
Which is bigger, ACON or BGLC?
ACON is 1.8 times larger than BGLC by market capitalization ($5M against $3M).
Which one does Intratio's AI model rank higher, ACON or BGLC?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.